4.5 Article

Evaluation of 18F-labeled icotinib derivatives as potential PET agents for tumor imaging

Journal

JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
Volume 309, Issue 2, Pages 517-523

Publisher

SPRINGER
DOI: 10.1007/s10967-015-4671-7

Keywords

Quinazoline derivatives; Biodistribution; F-18; PET

Funding

  1. National Natural Science Foundation of China [21071022]
  2. Fundamental Research Funds for the Central Universities

Ask authors/readers for more resources

In this study, three F-18-labeled crown ether fused anilinoquinazoline derivatives ([F-18]11a-c) were synthesized and evaluated as potential tumor imaging probes. The biodistribution results of [F-18]11b were good. Compared with [F-18]-fludeoxyglucose and l-[F-18]-fluoroethyltyrosine in the same animal model, [F-18]11b had better tumor/brain, tumor/muscle, and tumor/blood uptake ratios. Overall, these results suggest that [F-18]11b is promising as a tumor imaging agent for positron emission tomography.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available